Importantly, the tolDCs are capable of inducing regulatory T cells (Tregs), as well as quelling autoreactive CD4+ and CD8+ T cells in an antigen-specific manner [27], providing a precision therapeutic approach for autoimmune diseases. Here, CD4 is linked to autoimmune disease.